What Joanna spoke about.

At the plenary session in Strasbourg on 5-9 July, during the debate on the state of play of the implementation of the EU Digital COVID Certificate legislation, the European Commission expressed its full satisfaction with the extremely swift process of agreeing on the Regulation, stressing that the Regulation entered into force on 1 July 2021 and that the Certificate itself will be valid in all EU

Madam President, I'm sorry. Dear Commissioner, When I read the original draft of the European Commission more than a year ago, I doubted whether this very comprehensive and innovative project had any chance of success and whether it interfered too much with our privacy or national health systems. However, I must admit that the joint ENVI and LIBE Committees have managed to work out a text that sig

Mr President, thank you very much. Dear Commissioner, The problem of lack of medicines is not a new challenge, and the current debate is not the first attempt to exchange views to counteract this risky situation for patients. All Member States are experiencing problems related to shortages of medicines. There is a lack of cardiac drugs, drugs used in respiratory diseases, antibiotics and advanced

Mr President, thank you very much. Mr. Commissioner, I'm sorry. Despite the ban on the use of asbestos throughout the Union in 2005, it is still the leading cause of occupational cancer in the European Union and is responsible for tens of thousands of deaths per year. I support the agreement reached after the trilogue. New precautions, improved information on asbestos-containing materials, the cre

Madam President, I'm sorry. Dear Commissioner, The misuse of antimicrobials has led to the growing problem of antimicrobial resistance over time, to the point that this threat has been identified as one of the top ten global public health challenges. Therefore, when I addressed interpellations to the Commission last year with regard to the criteria for the designation of antimicrobials, the respon

Madam President, I'm sorry. Dear Commissioner, Recently, the global debate on public health has become a lively topic. On the one hand, I am unquestionably in favour of prioritising global health through appropriately selected programmes financed, inter alia, from the European Union budget, such as the EU4Health programme, Horizon Europe, the Neighbourhood and International Cooperation Instrument

Mr President, thank you very much. Dear Commissioner, Ladies and Gentlemen, Access to medicines is a matter of patient safety and the term ‘health security’ always opens up a serious discussion on all forms of an appropriate response to any public health emergency. The health security of the European Union has recently been put at risk by the sharp increase in cases of bacterial infections followi

Madam President, I'm sorry. Commissioner, I'm sorry. Ladies and Gentlemen, Diabetes is one of the most dangerous and most common chronic civilization diseases. In the European Union, as the Commissioner mentioned, more than 33 million people are suffering from it, and it is estimated that in less than eight years the number will rise to 38 million. Moreover, it is estimated that at some stage of t

Mr President, thank you very much. Dear Commissioner, Ladies and Gentlemen, This is a very important debate. The number of people affected by mental health problems is constantly increasing, and according to recent estimates, one in three people struggling with mental health problems do not have access to professional medical care. In addition, this has been aggravated by the COVID-19 pandemic. Fo

Mr President, thank you very much. In its conclusions of 27 April this year, the Commission notes that the COVID-19 pandemic will have wide-ranging effects on public health, an undisputed impact on health systems, a slowdown in economic processes and even the way of life to date. Member States are encouraged to develop key actions to protect public health, while maintaining the openness and resili

Madam President, I'm sorry. Commissioner, I'm sorry. Ladies and Gentlemen, Thank you for all your comments and comments, for your joint, intensive and reliable work. I would also like to thank Commissioner Stella Kyriakides for the proposal for a regulation put forward by the Commission in the Health Union package. I would also like to thank you for your help with the Agency's budget records. I wo

Madam President, I'm sorry. Commissioner, I'm sorry. Ladies and Gentlemen, After almost two years of legislative work on the European Health Union package, we now proceed to endorse two key elements of the European Health Union package – a strengthened mandate for the European Centre for Disease Prevention and Control (ECH) and a strengthened mandate for the European Health Union. Disease Preventi

Madam President, I'm sorry. Dear Commissioner, Achieving the 2030 target will be a particular challenge for the countries of Central and Eastern Europe. We want to carry out the climate and energy transition, but we must have adequate support for this. However, it is incomprehensible to us that, on the one hand, you are raising the targets, you want us to move away from all fossil fuels, and on th

Mr President, thank you very much. Mr. Commissioner, I'm sorry. Dear Colleagues, Occupational cancer statistics are still alarming, and behind each of these statistics are people who lose their lives and health. More than half of work-related deaths are due to cancer, and many work-related cancers are preventable. It is therefore our duty to make every effort to ensure that the right tools are in

Madam President, I'm sorry. Commissioner, I'm sorry. I support the report, which is a summary of the work of the Special Committee on Agriculture and Rural Development. Fighting Cancer. For 15 months here in the European Parliament, we have been trying to make sure that recommendations from hearings and conferences on cancer can take on real significance in the everyday struggles of patients, thei

Madam President, I'm sorry. Honourable rapporteur, I share the view that harmonisation of tools, data sources and HTA methodology should be promoted, as well as unnecessary duplication of work should be reduced. I am in favour of an HTA where the results of the joint clinical assessment report are duly taken into account but are not an obligation. I would call the other initiatives on HTA better t

Madam President, I'm sorry. Commissioner, thank you very much. I support the revision of the European Union Action Plan on Rare Diseases, the overarching objective of which is to ensure that no patient affected by a rare disease is left unattended by 2030. It seems reasonable for the ERNs and existing national plans and strategies to gain new synergies, given that we do not have a comprehensively

Madam President, I'm sorry. Commissioner, thank you very much. The term ‘global village’ has long become synonymous with the current reality. Nevertheless, the example of the pandemic shows that the functioning of this village also means facing significant inequalities. Given the COVID-19 vaccination rates, we can see extremely large disparities, especially in developing countries, with regard to

Madam President, I'm sorry. Commissioner, thank you very much. Ladies and Gentlemen, I support the adoption of the report on the Pharmaceutical Strategy for Europe, as I am in favour of efforts to ensure the availability and affordability of medicines for all patients. Long before the outbreak of the pandemic, I took initiatives to restore the independence of the production of medical substances a

Mr President, thank you very much. Mr. Commissioner, I'm sorry. Ladies and Gentlemen, Despite the general European ban on asbestos, it is still present in our constructions and remains a threat to public health. The tragic consequences of exposure to asbestos – in particular mesothelioma or lung cancer – are affecting many citizens and workers in the European Union, especially workers in the const

Madam President, I'm sorry. Dear Commissioner, The establishment of a new health security architecture with specific tasks on critical medical countermeasures is set to become one of the pillars of health union security. The Office's activities are to become the main objective of strengthening the European Union's capacity and filling the gap in the EU's response and preparedness system in health

Madam President, I'm sorry. Commissioner, I'm sorry. Patient safety and access to medicines are two key words that open the discussion about crisis response and the right response to a public health emergency. I support those EU solutions that can make a real contribution to a higher level of human health protection by strengthening the Union's response capacity. This includes today's report on th